TITLE:
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

CONDITION:
Diabetes

INTERVENTION:
insulin human

SUMMARY:

      This trial is conducted in the United States of America (USA). The aim of this trial is to
      to determine whether insulin aspart can be used effectively and safely in paediatric
      patients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 6 Years to 18 Years
Criteria:

        Inclusion Criteria:

          -  Pediatric patients with Type 1 diabetes for at least one year

          -  HbA1c less than 12%

          -  Willing to administer at least 3 injections per day

          -  Willing to perform self monitored blood glucose (SMBG) at least 4 times per day,
             includes subject and/or parent/guardian, as necessary
      
